Skip to main content
Log in

Atomoxetine-induced life-threatening long QT syndrome

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Biederman J, Monuteaux MC, Kendrick E et al (2005) The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Arch Dis Child 90:1010–1015

    Article  PubMed  CAS  Google Scholar 

  2. Russell V, Allie S, Wiggins T (2000) Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Behav Brain Res 117:69–74

    Article  PubMed  CAS  Google Scholar 

  3. Rajesh AS, Bates G, Wright JG (2006) Atomoxetine-induced electrocardiogram changes. Arch Dis Child 91:1023–1024

    Article  PubMed  CAS  Google Scholar 

  4. Wernicke JF, Faries D, Girod D et al (2003) Cardiovascular effects of atomoxetine in children, adolescents and adults. Drug Saf 26:729–740

    Article  PubMed  CAS  Google Scholar 

  5. Loghin C, Haber H, Beasley CM et al. (2012) Effects of atomoxetine on the qt interval in healthy CYP2D6 poor metabolizers. Br J Clin Pharmacol [Epub ahead of print]

  6. Seifi A, Griffith H, Avestimehr S et al (2011) Atomoxetine-induced myocardial infarction. South Med J 104:153–154

    Article  PubMed  Google Scholar 

  7. Li WY, Strang SE, Brown DR et al (2010) Atomoxetine changes rat’s HR response to stress from tachycardia to bradycardia via alterations in autonomic function. Auton Neurosci 154:48–53

    Article  PubMed  CAS  Google Scholar 

  8. Drew BJ, Ackerman MJ, Funk M et al (2010) Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 55:934–947

    Article  PubMed  Google Scholar 

  9. Graham J, Banaschewski T, Buitelaar J, European Guidelines Group et al (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37

    Article  PubMed  CAS  Google Scholar 

  10. Hennessy S, Schelleman H, Daniel GW et al (2010) Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study. Pharmacoepidemiol Drug Saf 19:934–941

    Article  PubMed  Google Scholar 

  11. Roden DM (2006) Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 259:59–69

    Article  PubMed  CAS  Google Scholar 

  12. Scherer D, Hassel D, Bloehs R et al (2009) Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents. Br J Pharmacol 156:226–236

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interests

The authors have no personal affiliations, financial relationship or any commercial interest to disclose relative to this article. The submitted report or any essential part of it is not published or simultaneously submitted to other publications prior to its appearance in this Journal.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Štuhec.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Štuhec, M., Švab, V. Atomoxetine-induced life-threatening long QT syndrome. Ir J Med Sci 182, 535–537 (2013). https://doi.org/10.1007/s11845-013-0925-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-013-0925-y

Keywords

Navigation